![](http://www.alamy.com/thumbs/6/E5A79A69-156F-4CB3-B948-E8DF3268F3E4/JFHP5K.jpg)
Eculizumab monoclonal antibody drug. Targets complement component 5 and indications for use include paroxysmal nocturnal hemoglobinuria (PNH) and Atyp
Eculizumab monoclonal antibody drug. Targets complement component 5 and indications for use include paroxysmal nocturnal hemoglobinuria (PNH) and Atypical hemolytic uremic syndrome (aHUS). Generic name and stylized antibody.
Size: 9000px × 3535px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No
Keywords: ahus, antibody, atypical, biological, biosimilar, biotech, biotechnology, c5, cascade, complement, component, disease, drug, eculizumab, excessive, expensive, hemoglobinuria, hemolytic, immunoglobulin, immunology, infusion, inhibitor, injection, inn, mab, monoclonal, nocturnal, nomenclature, orphan, paroxysmal, peptide, pnh, price, protein, syndrome, terminal, uremic